EUVIMEDEUVIMED entdecken
Open Access

Monocyte-to-Platelet Ratio Shows Modestly Improved Discrimination Over Model for End-Stage Liver Disease (MELD) 3.0 in Predicting 1-Year Mortality in Patients With Chronic Liver Failure and Hepatic Encephalopathy

Jing-Tao Qin, Xue-Ming Zhang, Kai Liu, Yi-Shan He, Shu-Qin Zheng, Yuan Xue

Cureus · 31.07.2026

DOI: 10.7759/cureus.113713 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 31.07.2026. Verfasst von Jing-Tao Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Xuzhou Medical University-Affiliated Changzhou Hospital, Changzhou, CHN. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

chronic liver failurehepatic encephalopathymodel for end-stage liver diseasemonocyte-to-platelet ratiorisk score

Autor:innen und Institutionen

  • Department of Infectious Diseases, Xuzhou Medical University-Affiliated Changzhou Hospital, Changzhou, CHN.

Zitieren

APA

Qin, J. T., Zhang, X. M., Liu, K., He, Y. S., Zheng, S. Q., & Xue, Y. (2026). Monocyte-to-Platelet Ratio Shows Modestly Improved Discrimination Over Model for End-Stage Liver Disease (MELD) 3.0 in Predicting 1-Year Mortality in Patients With Chronic Liver Failure and Hepatic Encephalopathy. Cureus. https://doi.org/10.7759/cureus.113713

Vancouver

Qin JT, Zhang XM, Liu K, He YS, Zheng SQ, Xue Y. Monocyte-to-Platelet Ratio Shows Modestly Improved Discrimination Over Model for End-Stage Liver Disease (MELD) 3.0 in Predicting 1-Year Mortality in Patients With Chronic Liver Failure and Hepatic Encephalopathy. Cureus. 2026. doi:10.7759/cureus.113713

BibTeX
@article{Qin2026,
  author = {Qin, Jing-Tao and Zhang, Xue-Ming and Liu, Kai and He, Yi-Shan and Zheng, Shu-Qin and Xue, Yuan},
  title = {Monocyte-to-Platelet Ratio Shows Modestly Improved Discrimination Over Model for End-Stage Liver Disease (MELD) 3.0 in Predicting 1-Year Mortality in Patients With Chronic Liver Failure and Hepatic Encephalopathy},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.113713}
}
Kostenlos starten →